Pioneering Deep Tech Institute Inc
Nonprofit profile at a glance
- EIN
- 880691219
- IRS 990 coverage
- 2025–2025
- Forms available
- Form 990 2025, Form 990-N 2024
- Location
- Cottonwood Heights, UT, USA
- Phone
- 9149547709
- Rating confidence
- Limited
- Sector
- Human Service Organizations
Reported finances
- Revenue
- $0
- Expenses
- $9,311
- Assets
- $9
- Liabilities
- $22,900
Source: IRS Form 990. Selected filing: tax year 2025. Amounts in USD.
Leadership & pay
3 people listed
Executive titles in this filing
- Andrew Piskadlo (President Treasurer)
- Nicholas C Witham (Vice President)
People named in this filing
- Andrew Piskadlo (President Treasurer)
- Nicholas C Witham (Vice President)
- Michael Greenwald (Secratary)
Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.
Source: IRS Form 990. Selected filing: tax year 2025. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
Pioneering Deep Tech Institute PDTI is a 501c3 nonprofit that incubates and accelerates community-benefit deep-technology ventures by providing shared facilities targeted capital and experienced legal and regulatory support from early feasibility through MVP and initial commercialization. Our model is explicitly founder-aligned: we do not capture intellectual property and we structure participation through a modest product-linked stake designed to sustain the organizations exempt activities. We are selective and focus only on projects with a clear community-benefit multiplier. In parallel we conduct and sponsor select scholarly research and publications and we develop expert-led educational programs so practitioners policymakers and the public can better understand and govern emerging technologies.
What it reported doing in 2025
PROGRAM 2 - POINT-OF-CARE MEDICAL DIAGNOSTIC UColIV POC Diagnostic. Continuing research program targeting a quantitative low-resource-setting diagnostic for urinary collagen type IV - a marker of microvascular and kidney function relevant to chronic kidney disease and hypertension-associated nephropathy. URI submitted two competitive NIH applications for this program in 2023 R21 mechanism in June application ID GRANT13924257; SBIR mechanism in September same application number; both not funded. The TY2025 antibody procurement from Abcam Inc. 6,516.53 combined settled by ACH on 4 29 2025 supported preparation of the Corporations preliminary clinical-validation manuscript reporting Spearman rho equal to 0.631 P equal to 9.5 times 10 to the negative 4 n=24 between urinary collagen type IV and estimated glomerular filtration rate in a clinical sample. The manuscript is in preparation for submission to Kidney International Reports.
Operating model
- Revenue model
- No positive adjusted resources. The filing reports no positive adjusted operating resources.
- Distribution model
- Direct operator. The filing allocates 100% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.
The verdict
- The available evidence is not sufficient to produce an overall rating for this filing. This is not a warning sign.
Rating breakdown
- Financial Efficiency: 59
- Transparency & Controls: 90
- Accountability: 70
- Sustainability: 9
- Growth: NotEnoughData
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: Limited
- Program expense ratio: 79%; rating input score 79
- Fundraising efficiency: Limited
Transparency & Controls
- Consistency checks: 100%; rating input score 100; 63rd percentile among comparable filings
- Pay-setting controls: Limited
- Foreign activity oversight: Limited
- Grant itemization coverage: Limited
- Major donor itemization: Limited
- Related-party transparency: Limited
Accountability
- Independent voting board: 100%; rating input score 100; 64th percentile among comparable filings
- Governance controls: 2 of 7 controls in place; rating input score 29
- Conflict-of-interest policy: Pass
- Whistleblower policy: Fail
- Document-retention policy: Fail
- CEO compensation review process: NotApplicable
- Other executive compensation review process: NotApplicable
- Form 990 shared with the board: Pass
- Board meeting minutes documented: Fail
- Audit committee oversight: Missing
- Independent financial-statement audit: Fail
Sustainability
- Operating margin: Limited
- Total-asset coverage ratio: 0; rating input score 6; 6th percentile among comparable filings
- Liabilities to assets ratio: 2,544.44; rating input score 0; 0th percentile among comparable filings
- Officer compensation ratio: 0%; rating input score 58; 58th percentile among comparable filings
Growth
- Program expense growth: Limited
- Revenue growth: Limited
- Asset growth: Limited
Details
- Where the money goes: 79% of spending went to programs
- Governance: 3 of 3 board members independent · 2 of 7 filing controls reported
- Programs: 3 filed program accomplishments · $7K in reported program spending
- Leadership: top reported pay $0 · 3 people listed
- Consistency: 40 of 40 current checks pass
- Schedules: 3 filed schedules
- Contacts: How to reach this organization
- Money network: 1 filed money-flow record
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
- High — Accountability: Governance controls: 4 of 6 not reported.
- High — Sustainability: Total-asset coverage ratio scored 6/100.
- High — Sustainability: Liabilities to assets ratio scored 0/100.
- Review — Sustainability: Officer compensation ratio scored 58/100.